MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020.
carcinoma
miRNA
microRNA
microcarcinoma
papillary
thyroid
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Oct 2020
25 Oct 2020
Historique:
received:
09
09
2020
revised:
19
10
2020
accepted:
21
10
2020
entrez:
29
10
2020
pubmed:
30
10
2020
medline:
30
10
2020
Statut:
epublish
Résumé
The involvement of micro-ribonucleic acid (microRNAs) in metabolic pathways such as regulation, signal transduction, cell maintenance, and differentiation make them possible biomarkers and therapeutic targets. The purpose of this review is to summarize the information published in the last two and a half years about the involvement of microRNAs in papillary thyroid carcinoma (PTC). Another goal is to understand the perspective offered by the new findings. Main microRNA features such as origin, regulation, targeted genes, and metabolic pathways will be presented in this paper. We interrogated the PubMed database using several keywords: "microRNA" + "thyroid" + "papillary" + "carcinoma". After applying search filters and inclusion criteria, a selection of 137 articles published between January 2018-June 2020 was made. Data regarding microRNA, metabolic pathways, gene/protein, and study utility were selected and included in the table and later discussed regarding the matter at hand. We found that most microRNAs regularly expressed in the normal thyroid gland are downregulated in PTC, indicating an important tumor-suppressor action by those microRNAs. Moreover, we showed that one gene can be targeted by several microRNAs and have nominally described these interactions. We have revealed which microRNAs can target several genes at once.
Identifiants
pubmed: 33113852
pii: cancers12113118
doi: 10.3390/cancers12113118
pmc: PMC7694051
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Biomed Pharmacother. 2019 Jan;109:1960-1966
pubmed: 30551451
Onco Targets Ther. 2019 Aug 16;12:6605-6616
pubmed: 31496749
Cell Death Dis. 2018 Mar 7;9(3):380
pubmed: 29515109
Onco Targets Ther. 2020 Feb 13;13:1311-1319
pubmed: 32103998
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3421-3430
pubmed: 31081096
Hum Cell. 2019 Oct;32(4):428-436
pubmed: 31161410
J Cell Biochem. 2019 Jun;120(6):10830-10846
pubmed: 30706537
J Cell Physiol. 2020 Mar;235(3):2492-2505
pubmed: 31565805
Thyroid. 2018 Sep;28(9):1162-1173
pubmed: 29882471
Int J Genomics. 2017;2017:6496570
pubmed: 29038786
Oncol Lett. 2018 Jan;15(1):1007-1013
pubmed: 29399161
Mol Diagn Ther. 2018 Feb;22(1):41-56
pubmed: 28986854
Int J Mol Med. 2018 Dec;42(6):3027-3036
pubmed: 30272290
Drug Dev Res. 2018 Nov;79(7):324-331
pubmed: 30267584
Biomed Pharmacother. 2019 Oct;118:109298
pubmed: 31404776
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8429-8439
pubmed: 31646573
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3431-3439
pubmed: 31081097
Biomed Res Int. 2020 Jan 9;2020:4983420
pubmed: 31998791
Life Sci. 2020 Jun 1;250:117519
pubmed: 32147429
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6570-6578
pubmed: 31378898
Cancer Lett. 2019 Feb 28;443:145-156
pubmed: 30503553
BMC Endocr Disord. 2019 Nov 12;19(1):122
pubmed: 31718630
Exp Ther Med. 2018 Jul;16(1):45-52
pubmed: 29896226
Cell Cycle. 2020 May;19(10):1105-1121
pubmed: 32308106
Cell Cycle. 2019 Jan;18(2):167-203
pubmed: 30596336
J Cell Physiol. 2020 Oct;235(10):6615-6624
pubmed: 32048306
Oncol Lett. 2018 Oct;16(4):5237-5242
pubmed: 30250593
Biomed Pharmacother. 2018 Jun;102:988-995
pubmed: 29710554
Onco Targets Ther. 2020 Feb 04;13:1037-1046
pubmed: 32099406
Med Sci Monit. 2018 Aug 07;24:5488-5500
pubmed: 30086127
Endocr Relat Cancer. 2019 May;26(5):525-538
pubmed: 30870812
Endocrine. 2019 Aug;65(2):318-326
pubmed: 31030335
Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2453-2460
pubmed: 30964171
Medicine (Baltimore). 2019 Jun;98(25):e16050
pubmed: 31232941
Neoplasma. 2018 Nov 15;65(6):933-942
pubmed: 29940766
Cell Cycle. 2020 May;19(10):1186-1199
pubmed: 32306838
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8940-8949
pubmed: 31696481
Cell Physiol Biochem. 2018;50(5):1659-1672
pubmed: 30384358
Int J Clin Exp Pathol. 2019 Aug 01;12(8):3128-3133
pubmed: 31934155
Cell Death Dis. 2019 Aug 14;10(8):620
pubmed: 31409775
Mol Med Rep. 2019 Mar;19(3):1903-1910
pubmed: 30628685
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7989-7999
pubmed: 31599424
Int J Oncol. 2019 Jan;54(1):315-325
pubmed: 30387841
Med Sci Monit. 2019 Sep 10;25:6788-6796
pubmed: 31501407
Cell Death Dis. 2019 Jun 3;10(6):433
pubmed: 31160577
Biochem Biophys Res Commun. 2019 Mar 5;510(2):334-338
pubmed: 30709584
Int J Mol Sci. 2018 Jun 26;19(7):
pubmed: 29949872
Mol Med Rep. 2018 Sep;18(3):3059-3067
pubmed: 30015945
J Cell Physiol. 2019 Jul;234(7):11431-11439
pubmed: 30478856
Biomed Pharmacother. 2019 Jun;114:108605
pubmed: 30904818
Neoplasma. 2019 Jul 23;66(4):516-523
pubmed: 30868891
Cell Transplant. 2020 Jan-Dec;29:963689720918300
pubmed: 32425116
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1145-1150
pubmed: 30779083
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5562-5568
pubmed: 30229829
IUBMB Life. 2019 Jan;71(1):28-40
pubmed: 30325582
Sci Rep. 2020 Mar 12;10(1):4616
pubmed: 32165673
Adv Exp Med Biol. 2013;774:1-20
pubmed: 23377965
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1134-1144
pubmed: 30779082
Oncol Lett. 2018 Sep;16(3):2965-2970
pubmed: 30127885
Ann Transl Med. 2019 Nov;7(22):643
pubmed: 31930044
Biochem Biophys Res Commun. 2019 Dec 3;520(2):277-283
pubmed: 31590919
Cell Prolif. 2019 Mar;52(2):e12569
pubmed: 30657221
Eur Thyroid J. 2019 Oct;8(5):227-245
pubmed: 31768334
Saudi J Biol Sci. 2018 Jul;25(5):986-990
pubmed: 30108452
Cancer Biomark. 2018;22(4):727-732
pubmed: 29945344
Mol Ther Nucleic Acids. 2020 Mar 6;19:1134-1144
pubmed: 32059339
Am J Cancer Res. 2018 Jun 01;8(6):1030-1039
pubmed: 30034940
Mol Med Rep. 2018 Aug;18(2):1674-1681
pubmed: 29845281
Oncol Lett. 2019 Mar;17(3):3355-3361
pubmed: 30867770
Endokrynol Pol. 2020;71(2):146-152
pubmed: 32154571
Mol Ther Nucleic Acids. 2020 Mar 6;19:741-750
pubmed: 31951855
Biosci Rep. 2019 Jan 11;39(1):
pubmed: 30429236
Biochem Biophys Res Commun. 2018 Sep 3;503(1):56-61
pubmed: 29842886
Biomed Pharmacother. 2018 Sep;105:1072-1078
pubmed: 30021343
Oncol Lett. 2018 Sep;16(3):3561-3568
pubmed: 30127962
Mol Med Rep. 2019 Feb;19(2):1403-1409
pubmed: 30569166
Biochem Biophys Res Commun. 2019 Jan 22;508(4):1145-1148
pubmed: 30553447
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5851-5862
pubmed: 31298336
J Cell Physiol. 2019 Aug;234(10):18382-18391
pubmed: 30941771
Biomed Pharmacother. 2019 Feb;110:528-536
pubmed: 30530288
Bosn J Basic Med Sci. 2019 May 20;19(2):146-154
pubmed: 30114378
Onco Targets Ther. 2019 Jun 28;12:4869-4881
pubmed: 31388302
Biomed Pharmacother. 2019 Jan;109:2357-2364
pubmed: 30551495
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2084-2091
pubmed: 30915753
Cell Biochem Funct. 2020 Jun 3;:
pubmed: 32495394
Pathol Res Pract. 2020 Apr;216(4):152856
pubmed: 32098696
Cancer Cell Int. 2019 Nov 12;19:287
pubmed: 31749660
Biochem Biophys Res Commun. 2018 Feb 26;497(1):181-186
pubmed: 29427661
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3804-3811
pubmed: 29949156
Onco Targets Ther. 2018 Mar 16;11:1501-1509
pubmed: 29593418
Ann Oncol. 2019 Dec 1;30(12):1856-1883
pubmed: 31549998
J Cell Physiol. 2019 Feb;234(2):1336-1345
pubmed: 30146756
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4890-4900
pubmed: 32432752
Oncol Rep. 2018 Dec;40(6):3611-3624
pubmed: 30542708
Med Sci Monit. 2018 Dec 09;24:8899-8909
pubmed: 30531691
Biomed Pharmacother. 2018 Oct;106:983-990
pubmed: 30119270
Oncol Res. 2019 Jun 21;27(6):691-701
pubmed: 30832753
Cancer Manag Res. 2018 Dec 17;11:13-23
pubmed: 30588107
Pathol Res Pract. 2018 Nov;214(11):1787-1793
pubmed: 30166214
Acta Biochim Biophys Sin (Shanghai). 2019 Aug 5;51(8):807-813
pubmed: 31257410
J Cell Physiol. 2018 Oct;233(10):6638-6648
pubmed: 29319165
J BUON. 2014 Apr-Jun;19(2):524-9
pubmed: 24965416
Int J Biochem Cell Biol. 2018 May;98:1-9
pubmed: 29474928
Onco Targets Ther. 2019 Mar 28;12:2323-2333
pubmed: 30992669
J Cell Mol Med. 2019 Dec;23(12):8067-8075
pubmed: 31559672
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):168-172
pubmed: 30415780
Oncol Lett. 2017 Jun;13(6):4252-4266
pubmed: 28599426
Exp Mol Pathol. 2020 Feb;112:104342
pubmed: 31738908
Life Sci. 2020 Mar 1;244:117298
pubmed: 31953163
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3430-3438
pubmed: 29917195
Cell Death Dis. 2019 Feb 27;10(3):195
pubmed: 30814512
Cell Death Dis. 2018 Sep 20;9(10):947
pubmed: 30237435
J Clin Lab Anal. 2020 Feb;34(2):e23044
pubmed: 31670857
J Gene Med. 2019 May;21(5):e3083
pubmed: 30811764
Arch Biochem Biophys. 2020 May 30;685:108353
pubmed: 32234499
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32303750
Cell Death Dis. 2019 Feb 22;10(3):184
pubmed: 30796202
Thyroid. 2018 Dec;28(12):1627-1641
pubmed: 30244634
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5863-5873
pubmed: 31298337
Anticancer Res. 2019 Jan;39(1):33-40
pubmed: 30591438
Biomed Pharmacother. 2020 Jul;127:109901
pubmed: 32335297
J Oncol. 2020 Jun 3;2020:2052396
pubmed: 32565797
Biomed Pharmacother. 2018 Aug;104:686-698
pubmed: 29803929
Anat Rec (Hoboken). 2019 Feb;302(2):258-268
pubmed: 30290400
Exp Ther Med. 2019 Jul;18(1):209-215
pubmed: 31258655
Horm Cancer. 2019 Dec;10(4-6):150-160
pubmed: 31317324
Biochem Biophys Res Commun. 2018 Sep 26;504(1):283-288
pubmed: 30190130
J Cell Physiol. 2019 Apr;234(4):4054-4067
pubmed: 30206929
Onco Targets Ther. 2019 Aug 06;12:6217-6226
pubmed: 31496725
J Cell Biochem. 2018 Nov;119(11):8763-8772
pubmed: 30126001
Onco Targets Ther. 2019 Sep 06;12:7307-7321
pubmed: 31564913
Cancer Biother Radiopharm. 2020 Apr 24;:
pubmed: 32343601
Oncol Lett. 2020 Apr;19(4):3071-3078
pubmed: 32218861
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):326-335
pubmed: 31878795
Biol Res. 2019 Dec 23;52(1):61
pubmed: 31870440
Hum Gene Ther. 2019 May;30(5):618-631
pubmed: 30375256
Am J Transl Res. 2019 Nov 15;11(11):6826-6837
pubmed: 31814890
Cancer Biother Radiopharm. 2019 Nov;34(9):572-580
pubmed: 31644316
Cell Cycle. 2020 Apr;19(7):787-800
pubmed: 32075502
Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418772652
pubmed: 29856242
Oncol Lett. 2020 Jan;19(1):61-68
pubmed: 31897115
Exp Ther Med. 2019 Jan;17(1):895-900
pubmed: 30651878
Exp Cell Res. 2020 Feb 15;387(2):111785
pubmed: 31877303
Oncol Lett. 2018 Nov;16(5):6815-6821
pubmed: 30333891
Biomed Pharmacother. 2018 Jun;102:203-211
pubmed: 29558717
J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440
pubmed: 30545990
J Cell Biochem. 2020 Feb;121(2):2009-2018
pubmed: 31692033
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2856-2862
pubmed: 31002136
J Cell Physiol. 2019 Nov;234(11):20980-20991
pubmed: 31102261